Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: A preliminary study

European Respiratory Journal

Volumn 25, Issue 3, 2005, Pages 490-493

  Khalid, M ^a   Al Saghir, A ^a   Saleemi, S ^a   Al Dammas, S ^a   Zeitouni, M ^a   Al Mobeireek, A ^a   Chaudhry, N ^a   Sahovic, E ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Allogeneic bone marrow transplant; Azithromycin; Bronchiolitis obliterans; Macrolides; Pulmonary function tests

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MACROLIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG TOLERANCE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OBSTRUCTIVE AIRWAY DISEASE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; HUMANS; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 14744290039     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00020804     Document Type: Article

References (27)

1. Ostrow D, Buskard N, Hill RS, Vickars L, Churg A. Bronchiolitis obliterans complicating bone marrow transplantation. Chest 1985; 87: 828-830.
2. Johnson FL, Stokes DC, Ruggiero M, Dalla-Pozza L, Callihan TR. Chronic obstructive airways disease after bone marrow transplantation. J Pediatr 1984; 105: 370-376.
3. Chan CK, Hyland RH, Hutcheon MA, et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987; 66: 327-340.
4. Tait RC, Burnett AK, Robertson AG, et al. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int J Radial Oncol Biol Phys 1991; 20: 1219-1227.
5. Schwarer AP, Hughes JM, Trotman-Deickenson B, Krausz T, Goldman JM. A chronic pulmonary syndrome associated with graft-versus host disease after allogeneic bone marrow transplantation. Transplantation 1992; 54: 1002-1008.
6. Beinert T, Dull T, Wolf K, et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1996; 1: 343-348.
7. Shulmann HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
8. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993; 14: 741-749.
9. Schultz KR, Green GJ, Wensley D, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994; 84: 3212-3220.
10. Wyatt SE, Nunn P, Hows JM, et al. Airways obstruction associated with graft-versus-host disease after bone marrow transplantation. Thorax 1984; 39: 887-894.
11. Yousem SA. The histological spectrum of pulmonary graft- versus-host disease in bone marrow transplant recipients. Hum Pathol 1995; 26: 668-675.
12. Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775-778.
13. Krowka MJ, Rosenow EC III, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237-246.
14. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999; 13: 1091-1112.
15. Gerhardt SG, McDyer JF, Girgis RE, et al. Bronchiolitis obliterans syndrome/obliterative bronchiolitis ameliorated by azithromycin. J Heart Lung Transplant 2003; 22: S27.
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
17. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
18. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166: 440-444.
19. Culic O, Erakovic V, Cepelak I, et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 2002; 450: 277-289.
20. Suzuki H, Asada Y, Ikeda K, Oshima T, Takasaka T. Inhibitory effect of eythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope 1999; 109: 407-410.
21. Ianaro A, Ialenti A, Maffa P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000; 292: 156-163.
22. Scaglione F, Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarythromycin. J Antimicrob Chemother 1998; 41: Suppl. B, 47-50.
23. Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997; 107: 1661-1666.
24. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157: 1829-1832.
25. Zeiger RS, Schatz M, Sperling W, Simon RA, Stevenson DD. Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma. J Allergy Clin Immunol 1980; 66: 438-446.
26. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2003; 168: 121-125.
27. Wolter J, Seeney S, Bell S, Bowler S, Masel P, McKormack J. Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax 2002; 57: 212-216.